ARWR vs. ACLLY
ARWR (Arrowhead Pharmaceuticals, Inc.) and ACLLY (Accelleron Industries AG ADR) are both stocks. ARWR operates in Biotechnology (Healthcare), while ACLLY operates in Aerospace & Defense (Industrials). Over the past 3 years, ARWR returned 32.51%/yr vs 69.19%/yr for ACLLY. At a 0.11 correlation, their price movements are largely independent.
Performance
ARWR vs. ACLLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARWR achieves a 23.51% return, which is significantly lower than ACLLY's 38.92% return.
ARWR
- 1D
- 0.22%
- 1M
- 9.41%
- YTD
- 23.51%
- 6M
- 18.84%
- 1Y
- 435.25%
- 3Y*
- 32.51%
- 5Y*
- -1.42%
- 10Y*
- 31.09%
ACLLY
- 1D
- 2.91%
- 1M
- 5.47%
- YTD
- 38.92%
- 6M
- 37.00%
- 1Y
- 60.50%
- 3Y*
- 69.19%
- 5Y*
- —
- 10Y*
- —
ARWR vs. ACLLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | 23.51% | 253.14% | -38.56% | -24.56% | 20.21% |
ACLLY Accelleron Industries AG ADR | 38.92% | 56.70% | 69.48% | 60.55% | 2.00% |
Correlation
The correlation between ARWR and ACLLY is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Oct 4, 2022 | 0.11 |
Fundamentals
ARWR:
$11.68B
ACLLY:
$9.98B
ARWR:
-$2.16
ACLLY:
$4.29
ARWR:
18.39
ACLLY:
4.37
ARWR:
19.50
ACLLY:
20.91
ARWR:
$622.01M
ACLLY:
$2.28B
ARWR:
$529.27M
ACLLY:
$1.02B
ARWR:
-$168.38M
ACLLY:
$569.11M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARWR vs. ACLLY — Risk / Return Rank
ARWR
ACLLY
ARWR vs. ACLLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Accelleron Industries AG ADR (ACLLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARWR | ACLLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.87 | ||
| Sortino ratioReturn per unit of downside risk | +2.63 | ||
| Omega ratioGain probability vs. loss probability | 1.68 | 1.33 | +0.35 |
| Calmar ratioReturn relative to maximum drawdown | 17.81 | 3.18 | +14.63 |
| Martin ratioReturn relative to average drawdown | 49.05 | 5.83 | +43.22 |
Loading charts...
Drawdowns
ARWR vs. ACLLY - Drawdown Comparison
The maximum ARWR drawdown since its inception was -99.24%, which is greater than ACLLY's maximum drawdown of -30.00%. Use the drawdown chart below to compare losses from any high point for ARWR and ACLLY.
Loading charts...
Drawdown Indicators
| ARWR | ACLLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.24% | -30.00% | -69.24% |
Max Drawdown (1Y)Largest decline over 1 year | -24.64% | -19.13% | -5.51% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -28.69% | -46.01% |
Max Drawdown (5Y)Largest decline over 5 years | -88.94% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -88.96% | — | — |
Current DrawdownCurrent decline from peak | -49.54% | -7.54% | -42.00% |
Average DrawdownAverage peak-to-trough decline | -81.19% | -5.84% | -75.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.93% | 10.41% | -1.48% |
Volatility
ARWR vs. ACLLY - Volatility Comparison
Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 14.13% compared to Accelleron Industries AG ADR (ACLLY) at 9.10%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than ACLLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARWR | ACLLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.13% | 9.10% | +5.03% |
Volatility (6M)Calculated over the trailing 6-month period | 36.34% | 26.70% | +9.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.46% | 33.06% | +32.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.02% | 41.05% | +23.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.19% | 41.05% | +33.14% |
Dividends
ARWR vs. ACLLY - Dividend Comparison
ARWR has not paid dividends to shareholders, while ACLLY's dividend yield for the trailing twelve months is around 1.77%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ACLLY Accelleron Industries AG ADR | 1.77% | 1.94% | 2.95% | 4.04% |
ARWR Arrowhead Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ARWR vs. ACLLY - Financials Comparison
This section allows you to compare key financial metrics between Arrowhead Pharmaceuticals, Inc. and Accelleron Industries AG ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARWR and ACLLY have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARWR has higher volatility (14.13%) compared to ACLLY (9.10%). In terms of maximum drawdown, ARWR dropped -99.24% vs ACLLY's -30.00%.
ARWR currently has the higher Sharpe Ratio (6.72 vs 1.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARWR and ACLLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer